Physician profile
Michael A Trauner
NPI 1558460394
$1,283.24
in general payments reported to CMS, 2019-2025
17 companies · $20.59 in 2025
The $20.59 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.47 · 2021: $210 · 2022: $379 · 2023: $596 · 2024: $30.49 · 2025: $20.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $646.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $273.90 | 2022-2025 | Skyrizi, Rinvoq, Botox |
| Genzyme Corporation | $252.21 | 2022-2023 | |
| Eli Lilly and Company | $175.00 | 2021 | |
| Janssen Biotech, INC. | $85.58 | 2022-2023 | Tremfya |
| Pfizer INC. | $71.11 | 2023 | |
| Galderma Laboratories, L.P. | $70.70 | 2022-2023 | |
| Arcutis Biotherapeutics, INC. | $62.53 | 2023 | |
| Leo Pharma INC. | $45.22 | 2022-2023 | Adbry |
| Amgen INC. | $42.70 | 2022-2023 | Otezla |
| Glaxosmithkline, LLC. | $34.90 | 2021 | |
| Blueprint Medicines Corporation | $27.84 | 2023 | |
| Ucb, INC. | $27.62 | 2019 | |
| Incyte Corporation | $26.25 | 2022 | |
| Biofrontera INC. | $25.87 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
| Kyowa Kirin, INC. | $22.31 | 2023 | Poteligeo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $19.85 | 2019 | |
| Sun Pharmaceutical Industries INC. | $19.65 | 2023 | Blu-U, Odomzo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Trauner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.